NPC Member Spotlight: Michigan Reproductive Medicine

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

MRM

Overview

Michigan Reproductive Medicine has been freezing eggs since 2008 and is the first fertility center in Michigan to successfully freeze eggs and have babies born from frozen eggs.

Our center is committed to providing patients with the most up-to date technology. Fertility preservation by egg freezing is a true game-changer by providing women the greatest opportunity to control their reproductive futures.

Fertility Preservation Services Offered

An egg or embryo freezing cycle requires quick decision-making and communication between the patient, the woman’s oncologist and Dr. Mersol-Barg. Working together as a team and educating the patient about her cancer therapy’s impact on her fertility empowers the patient to make the best decision regarding her fertility preservation.

We provide the following services to women:

Embryo Freezing 

embryo

 

 

 

 

 

Egg Freezing 

egg


 

 

 

 

 

Contact Information

Please call Michigan Reproductive Medicine at (248) 593-6990 or visit our website at http://www.mireproductivemedicine.com/ to find out more about your fertility preservation options.

Michigan Reproductive Medicine

41000 Woodward Ave., Suite 100 East

Bloomfield Hills, MI 48304

Phone: 248-593-6990

Fax: 248-593-5925

Untitled

 

 

Michael S. Mersol-Barg, MD, Director, Michigan Reproductive Medicine

Email: Oncofertility@mireproductivemedicine.com

 

 

 

 

NPC Member Spotlight: Ann and Robert H. Lurie Children’s Hospital of Chicago

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

Screen Shot 2015-04-21 at 8.58.49 AM

Today, improved treatments of cancer and other diseases give patients the hope of long term survival. However, many of the treatments that increase survival may cause loss of fertility. New technologies in reproductive medicine are providing possibilities for preserving fertility.

Lurie Children’s is dedicated to working with families, patients and healthcare providers to guide them in deciding if fertility preservation is appropriate for their child.

As a member of the National Physicians Cooperative of the Oncofertility Consortium, Lurie Children’s Fertility Preservation Program offers services to pediatric, adolescent and young adult patients. This consortium of fertility experts, oncologists, surgeons, urologists, endocrinologists and researchers are working together to provide fertility preservation options to patients who are seeking to preserve fertility due to cancer treatment, surgery, or a congenital condition.

Fertility preservation options

We have a comprehensive range of services for pre- and post-pubertal patients. These include:

For Males

Testis shielding

Sperm cryopreservation

Testicular sperm extraction (TESE)

Testicular tissue freezing (experimental)

For Females

Ovarian shielding

Oophoropexy/ovarian transposition

Oocyte or embryo freezing

Ovarian tissue freezing (experimental)

Gonadotropin analogues (experimental)

The treatment team will work with you to determine the best options to suit your needs.

Each patient is unique, so fertility preservation must be tailored and carefully integrated with a patient’s treatment. Appropriate fertility preservation options depend on the age of the patient, as well as the treatment the patient is to receive. If treatment has been completed and there is a concern about the patient’s ability to have children, families are encouraged to seek a consultation with a fertility expert.

For more information or to schedule an appointment, please contact:

Barbara Lockart, DNP, APN/CNP, CPON, at Lurie Children’s at

312.227.4901.

oncofertility@luriechildrens.org

Multidisciplinary team of specialists

Our multidisciplinary team works together to ensure that every patient receives the best fertility preservation care available. This team consists of:

Oncology

Yasmin Gosiengfiao, MD

Attending Physician, Hematology/Oncology/Stem Cell Transplant; Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Barbara Lockart, DNP, APN/CNP, CPON

Pediatric Nurse Practitioner in Hematology/Oncology/Stem Cell Transplant; Patient Navigator for Fertility Preservation, Lurie Children’s Hospital

Pediatric Surgery

Marleta Reynolds, MD

Head, Pediatric Surgery; Professor of Surgery, Northwestern University Feinberg School of Medicine

Erin Rowell, MD

Attending Physician, Pediatric Surgery; Assistant Professor of Surgery, Northwestern University Feinberg School of Medicine

Endocrinology

Wendy Brickman, MD

Attending Physician, Endocrinology; Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Courtney Finlayson, MD

Attending Physician, Endocrinology; Instructor in Pediatrics, Northwestern University Feinberg School of Medicine

Jill Samis, MD

Attending Physician, Endocrinology, Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Reema Habiby, MD

Attending Physician, Endocrinology; Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Urology

Earl Cheng, MD

Division Head, Urology; Professor of Urology, Northwestern University Feinberg School of Medicine

Robert Brannigan, MD

Attending Physician, Urology,Northwestern Medicine; Professor of Surgery, Northwestern University Feinberg School of Medicine

Emilie Johnson, MD, MPH

Attending Physician, Urology; Assistant Professor of Urology, Northwestern University Feinberg School of Medicine

Elizabeth Yerkes, MD

Attending Physician, Urology; Associate Professor of Urology, Northwestern University Feinberg School of Medicine

Valerie Gillis, MMS, PA-C

Physician Assistant, Urology; Northwestern Medicine

Obstetrics and Gynecology/Reproductive Endocrinology and Infertility

Mary Ellen Pavone, MD,

Attending Physician, Reproductive Endocrinology and Infertility; Assistant Professor of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine

Kristin Smith

Patient Navigator for Fertility Preservation, Northwestern Medicine/Robert H. Lurie Comprehensive Cancer Center 

Research

Teresa Woodruff, PhD

Thomas J Watkins Professor of Obstetrics and Gynecology at the Feinberg School of Medicine; Chief of the Division of Fertility Preservation and Oncofertility Consortium

 

Find us on Social Media

Screen Shot 2015-03-31 at 9.50.53 AM

Did you know that the Oncofertility Consortium is accessible on multiple social media platforms?  You can find us on: Twitter, Facebook, Pinterest, YouTube as well as the blog!

Follow us, friend us, tweet us – we want to connect with all of you!

If you have news or events you wish to have highlighted, you can contact us directly through these social media accounts or email us at oncofertility@northwestern.edu.

 

Kevin J. Lederer Life Foundation

Screen Shot 2015-03-31 at 11.00.37 AM

The Oncofertility Consortium is excited to announce a new opportunity for Illinois individuals and couples struggling with infertility and its associated costs.  The Kevin J. Lederer Life Foundation is a 501c3 that will provide educational programs as well as financial assistance.  

The Foundation is not tied to any specific fertility group and grants are awarded on the financial and need-based determination of the medical board.  Grants can be used towards infertility treatment at any Illinois practice or towards the cost of adoption.  The Life grant application is now open and applications must be received by July 30, 2015.

 

Clinical Referrals: Cancer Knowledge Network

We welcome our Canadian Global Partners, Cancer Knowledge Network, as guests today on our blog.  Read on below for information about their program.

***************************************************

CKNLOGO_MainHiRez[1]

Fertility Clinic Referral for Breast Cancer Patients: The Sooner the Better

by Dr. Ellen Warner, MD, M.Sc., FRCPC, FACP

Contrary to long-held myths, we now know from well-designed studies that:

  1. Newly diagnosed breast cancer patients don’t just care about surviving breast cancer.  They also want to have normal lives once their treatment is over and retaining the ability to get pregnant is at the top of their agenda.  This is more of an issue now than it was several decades ago because, since women today tend to delay childbearing, many young breast cancer patients haven’t even started let alone completed their families.
  1. Getting pregnant after a breast cancer diagnosis, whether it ends in miscarriage or a healthy live birth, is safe even for patients with hormone sensitive (ER+) tumors.

This is excellent news for our young breast cancer patients.  But things are not so simple.  Chemotherapy damages the ovaries and probably shortens a woman’s natural fertility span by 5 to 10 years.   Tamoxifen, which is often prescribed for at least 5 years, doesn’t damage the ovaries but it does cause fetal malformations so women must not get pregnant while taking the drug. Since fertility drops with age, delaying pregnancy to take several years of tamoxifen means a greater risk of infertility.

Fortunately, there are now excellent fertility preservation options for women who need chemotherapy and/or tamoxifen but want to maximize their chance of having one or more babies in the future.   Women in stable relationships can have embryos (fertilized eggs) frozen while single women can freeze unfertilized eggs.  While both procedures require a brief period of hormonal stimulation to enable the harvesting of multiple eggs, studies to date show no evidence of an increase in cancer recurrence rates.  Fertility preservation takes several weeks, must be completed before chemotherapy or tamoxifen is started and may require difficult personal and financial decisions for some women.  Consequently, the earlier a woman is referred to a fertility specialist (ideally right after her breast cancer diagnosis), the more time she’ll have to make these decisions and the less likely it is that her cancer treatment will have to be delayed.

Discussion of fertility issues with all newly diagnosed breast cancer patients of reproductive age and early referral to a fertility clinic, if appropriate, has been strongly recommended by the American Society of Clinical Oncology.  Unfortunately, however, the majority of young breast cancer patients are not getting the opportunity to have fertility preservation.  Barriers include lack of information for oncologists and patients, and lack of access to fertility clinics.

In Canada, the new CKN Oncofertility Referral Network is a most welcome solution to these issues.  From our experience at our cancer centre with PYNK: Breast Cancer Program for Young Women, we have discovered that by disseminating fertility information to oncologists and patients, and with close co-operation between oncologists and fertility specialists, we can ensure that every patient (for whom fertility preservation is appropriate) receives a timely referral to a fertility clinic.  Thanks to the CKN Oncofertility Referral Network, young breast cancer patients across Canada will have the same opportunity.

Dr. Warner is a medical oncologist and Professor of Medicine at the University of Toronto who has been at the Odette Cancer Centre since 1993, where her practice and research have been devoted to breast cancer.  In 1994, she created a program for hereditary breast and ovarian cancer patients, which introduced genetic counseling and testing to the Odette Cancer Centre. Related research includes the determination of mutation prevalence in patient subgroups, gene-environment interactions and the development of validated educational materials for patients and physicians. Since 1997, she has led a study to explore the role of magnetic resonance imaging (MRI) in screening women with an inherited predisposition to develop breast cancer which has helped make annual MRI surveillance the standard of care for this very high risk population. Over the last few years she has created PYNK: Breast Cancer Program for Young Women, an interdisciplinary clinical and research program for young breast cancer patients which was officially launched in 2008. This program, the only one of its kind in Canada, addresses the unique tumour biology as well as the special medical and psychosocial needs of this population.

International Symposium on Fertility Preservation

We are pleased to announce that our Global Partners in India hosted a very successful international meeting February 28-March 1, 2015.  Here is a note from their center Director, Dr. Satish Kumar Adiga:

**************************************************************************

International Symposium on Fertility Preservation: From basic research to clinical applications

We had two reasons for organizing the International Symposium on Fertility Preservation which took place February 28th – March 1st in Manipal, India. First, we thought this would create a platform for experts from different disciplines to understand the need of fertility preservation as fertility preservation has still not gained much attention in India.

The second reason is to initiate and promote cutting edge research in Oncofertility as research in this area is still in its infancy and awaits more focus in India. Hence, we believed that this meeting helps in identifying research gaps, explore collaboration, identify new projects and strengthen research in this area.

There were about twenty special invited lectures spread over nine scientific sessions on different aspects of fertility preservation and a panel discussion. Experts from Oncology, Reproductive Endocrinology, Pediatrics, Andrology, Embryology and Basic science have attended and made this event truly interdisciplinary. In addition, young researchers and students were also presented their results in the poster sessions.

Global partnership with the Oncofertility Consortium created a platform for us to hold this meeting in Manipal. This partnership gave more visibility to this meeting and attracted delegates from all over the world. Though Dr. Woodruff could not attend the meeting due to prior commitments, we are thankful to her and OC for constant encouragement and support.  You can review our conference program here: International Symposium on Fertility Preservation Program

Screen Shot 2015-03-18 at 1.58.52 PMDr. Satish Kumar Adiga
Professor, Division of Clinical Embryology
Kasturba Medical College
Chair, Human Fertility & Clinical Embryology
Manipal University

 

 

NPC Member Spotlight: University of Illinois at Chicago

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

Screen Shot 2015-03-11 at 1.44.20 PM

UNIVERSITY of ILLINOIS at CHICAGO FERTILITY PRESERVATION PROGRAM

The University of Illinois Fertility Preservation Program offers a comprehensive team approach to help women faced with serious conditions which may impair futurefertility. Our team consists of reproductive endocrinologists, urologists, medical and surgical oncologists, rheumatologists, pathologists, embryologists, research and clinical nurses, social workers and clinical ethics consultants who are here to help. Please click here for more information on the UI Health Fertility Preservation Program.

We are members of the Oncofertility Consortium® National Physicians’ Cooperative and offer a wide range of options for patients who desire fertilitypreservation for medical and non-medical indications:

  • Embryo Freezing
  • Egg Freezing
  • Ovarian Tissue Freezing (Experimental)
  • Egg Donation

In addition, our Andrology Laboratory offers a patient (or Client Depositor) Sperm Bank service for long-term storage of an individual’s sperm for reasons such as reduction in fertility potential, prior to chemotherapy and/or radiation therapy for male oncology, or prior to vasectomy.  The Patient Sperm Bank is also used to store sperm extracted from the testes in the operating room, a procedure referred to as TESE (testicular sperm extraction).  Sperm from a TESE procedure can be stored short-term or long-term for subsequent use with the ICSI-IVF procedure for pregnancy attempts. Please click here for more information regarding the UIC Andrology Laboratory.

Our physicians at the University of Illinois Fertility Center are Board Certified specialists in Reproductive Endocrinology and Infertility.

Screen Shot 2015-03-11 at 1.49.43 PMBert Scoccia, MD

Professor of Obstetrics and Gynecology

Director of the Division of Reproductive Endocrinology and Infertility

Director of the University of Illinois Fertility Preservation Program

 

Screen Shot 2015-03-11 at 1.49.14 PMAlbert Asante, MD

Assistant Professor

Director of GYN Ultrasound Program

 

Screen Shot 2015-03-11 at 1.49.54 PMMusa Zamah, MD, PhD

Assistant Professor

Director of Residency Research Program

 

 

We will be happy to discuss our Fertility Preservation Program and any other issues with you during an office consultation:

1801 West Taylor Street, Suite 4A, Chicago, IL 60612

To make a new patient appointment, please call: UIC Call Center at 800-842-1002 or visit www.uicivf.org

Existing patients please call: UIC Fertility Center at 312-355-2740.

 

University of Illinois Andrology Laboratory

1801 West Taylor Street, Suite 4A, Chicago, IL 60612

To contact the Andrology Laboratory please call: (312) 996-7713

 

PATIENT RESOURCES

University of Illinois Fertility Preservation Program: http://www.uicivf.org

Oncofertility Consortium: http://www.oncofertility.northwestern.edu

Fertile Hope: http://www.fertilehope.org

Gilda’s Club Chicago: http://www.gildasclubchicago.org

 

 

NPC Member Spotlight: Reproductive Medicine Associates of New York

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

RMANY

Reproductive Medicine Associates of New York

The Division of Reproductive Endocrinology & Infertility of Mount Sinai at Reproductive Medicine Associates of New York is committed to preserving the dream of family building for reproductive age men and women who are diagnosed with cancer.  Our oncofertility program has been established to work quickly and closely with oncologists to meet the needs of our patients.  All patients who request fertility preservation are seen within 48 hours of their call, and in many cases, patients can start fertility preservation treatment within days.

Although chemotherapy, radiation and surgery are lifesaving, the treatment may compromise sperm and egg function.  Our male and female fertility preservation programs are designed to cryopreserve eggs, embryos or sperm before reproductive cells are lost.

RMA of New York uses the most advanced freezing technology to preserve reproductive cells. Vitrification (ultra-rapid-freezing) of oocytes (eggs) and embryos results in extremely high survival rates of cells.   Once frozen, the reproductive cells can be stored indefinitely and can be saved until family building is desired.

The RMA of New York Oncofertility Center of Excellence provides expert quality care, offers patients concierge services, and integrates care with medical and surgical oncologists. Patients undergoing cancer treatment typically have to coordinate care with multiple medical specialists, but the fertility care should not be challenging.  RMA of New York physicians serve on the faculty of the Mount Sinai School of Medicine, and are involved in extensive clinical research to further the science and hopes of reproductive medicine.

For more information, visit www.rmany.com or call 212.756.5777 to speak with a dedicated oncofertility specialist.

Exciting Updates from the Portuguese Center for Fertility Preservation

The Oncofertility Consortium Global Partner, The Portuguese Centre for Fertility Preservation (Coimbra Hospital and University Centre), now has brand new facilities! 

PORTUGALBLOG3 (2)Last December, the Portuguese heath minister launched the new space for this Oncofertility Centre, to support cancer patients in the preservation of their fertility and other reproductive decisions. Prior to this centre opening, the Portuguese Centre for Fertility Preservation was based within the Reproductive Medicine Department of Coimbra Hospital and University Centre.

The opening of the new Oncofertility facility is an important achievement in Portugal. On one hand, it is an acknowledgement by the Portuguese government that this field of intervention is important and, on the other hand, it can be tailored to the specific follow-up and monitoring needed for oncofertility patients as compared to traditional infertile couples.

Information about cancer-related infertility and the fertility preservation needs to be provided to oncologists and patients, but also to the general population. Keeping this in mind, the team of the  Portuguese Centre for Fertility Preservation have created a video to disseminate the message of Oncofertility, drawing attention to its importance and impact in the young cancer patients’ lives.

Be sure to check out their “Information makes all the difference” educational video – English translation available here: http://youtu.be/4Mcv0xSygbA

NPC Member Spotlight: Fertility Associates of Memphis

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

Screen Shot 2015-02-11 at 11.08.09 AMFertility Associates of Memphis

A major focus for our practice is to provide fertility preservation for those diagnosed with cancer. We offer patients struggling with cancer all options medically possible for the preservation and optimization of future fertility. These tools include in vitro fertilization with egg and embryo freezing, sperm freezing, radiation field minimizing surgery, and ovarian tissue freezing. Because this is a central part of our practice, we have considerable experience in all aspects of these technologies and work with some of the most respected institutions in the country, including St. Jude Children’s Research Hospital, to facilitate the best care for our patients.

Pediatric Fertility Preservation

As the functional Reproductive Endocrinology and Infertility division for St. Jude Children’s Research Hospital, we facilitate a wide range of fertility preservation strategies for children suffering with a cancer diagnosis. Our physicians all hold academic appointments at St. Jude and we conduct an onsite clinic in this facility to facilitate maximal accessibility. From our long established sperm freezing program for boys to our cutting edge egg freezing protocols for girls, we are helping children throughout our region and the world preserve hope for having family after cancer is a distant memory.

Adult Fertility Preservation

For the past several decades, Fertility Associates of Memphis has set the standard in the Mid-South region for offering the best available fertility preservation options for women and men with a cancer diagnosis. With the perfection and increased utilization of our egg freezing protocols, women with cancer are now routinely offered IVF with egg or embryo freezing prior to the initiation of chemotherapy or radiation, even in the setting of estrogen/progesterone positive breast cancer.

Our Physicians

Our physicians are experts in the field of Reproductive Endocrinology and Fertility, trained at some of the world’s most respected institutions including The Johns Hopkins University School of Medicine and Harvard University School of Medicine. In addition, our physicians regularly publish academic research give academic talks that help train other physicians from around the country and world how to best care for patients suffering with fertility related problems.

To make an appointment with any of the physicians at Fertility Associates of Memphis, please contact our office at 901-747-2229. We would be happy to help evaluate your fertility and explore steps you can take to maximize your chances of achieving pregnancy.

 

 

Page 1 of 5712345...102030...Last »
 
© Oncofertility Consortium Blog